Characteristics | Men | Women | Ratio Men/Women | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
n | % | Incidence per 100,000 | Median age at diagnosis | n | % | Incidence per 100,000 | Median age at diagnosis | ||||
Crude | Age-Standa | Crude | Age-Standa | ||||||||
All | 3404 | 100 | 10.0 | 7.4 (7.2–7.7) | 67.4 | 3442 | 100 | 9.6 | 6.6 (6.3–6.8) | 67.7 | 1: 1 |
Allb | 3363 | 100 | 9.8 | 7.3 (7.1–7.6) | 67.4 | 3094 | 100 | 8.7 | 6.0 (5.7–6.2) | 67.3 | 1.1: 1 |
Type of sarcoma | |||||||||||
Soft tissue sarcoma | 2371 | 69.7 | 6.9 | 5.1 (4.9–5.3) | 68.4 | 2556 | 74.3 | 7.1 | 4.8 (4.6–5.0) | 68.0 | 1: 1.1 |
Soft tissue sarcomab | 2334 | 69.4 | 6.8 | 5.0 (4.8–5.3) | 68.3 | 2214 | 71.6 | 6.2 | 4.2 (4.0–4.4) | 67.3 | 1.1: 1 |
Bone sarcoma | 299 | 8.8 | 0.9 | 0.8 (0.7–0.9) | 49.8 | 267 | 7.8 | 0.7 | 0.7 (0.6–0.8) | 54.0 | 1.1: 1 |
Bone sarcomab | 295 | 8.8 | 0.9 | 0.8 (0.7–0.9) | 49.8 | 261 | 8.4 | 0.7 | 0.7 (0.6–0.8) | 54.2 | 1.1: 1 |
GIST | 734 | 21.6 | 2.1 | 1.5 (1.4–1.6) | 69.5 | 619 | 18.0 | 1.7 | 1.1 (1.0–1.2) | 70.2 | 1.2: 1 |
Age at diagnosis (years) | |||||||||||
0–14 | 97 | 2.8 | 0.3 | – | – | 68 | 2.0 | 0.2 | – | – | 1.4: 1 |
15–29 | 158 | 4.6 | 0.5 | – | – | 117 | 3.4 | 0.3 | – | – | 1.4: 1 |
30–49 | 434 | 12.7 | 1.3 | – | – | 493 | 14.3 | 1.4 | – | – | 1: 1.1 |
50–69 | 1182 | 34.7 | 3.5 | – | – | 1214 | 35.3 | 3.4 | – | – | 1: 1 |
70+ | 1533 | 45.0 | 4.5 | – | – | 1550 | 45.0 | 4.3 | – | – | 1: 1 |
Total | 3404 | 100 | 10.0 | 7.4 | 67.4 | 3442 | 100 | 9.6 | 6.6 | 67.7 | 1: 1 |